U.S. Online Retail and Ecommerce Stock News

Dyne Therapeutics (DYN) has moved squarely into focus after it appointed veteran biopharmaceutical executive Barry E. Greene as an independent board member and expanded its loan facility with Hercules Capital to support upcoming milestones. See our latest analysis for Dyne Therapeutics. For context, Dyne Therapeutics shares trade at $20.33, with a 30-day share price return of 17.04% and a year-to-date share price return of 9.89%. The 1-year total shareholder return of 95.11% reflects strong...

Apple’s decision to lift MacBook and iPad prices as memory and storage costs climb is rippling through the entire consumer electronics sector, not just Apple stock. Higher input costs, rising average selling prices and potential shifts in demand are now key pressure points for manufacturers and suppliers alike. For investors, that raises the question of which consumer electronics manufacturers could be positioned to benefit from this AI driven memory squeeze, and which might feel more of a...

Earlier this year, TETRA Technologies reported one of its strongest first quarters in a decade, with revenue and adjusted EBITDA surpassing analyst expectations, supported by high-pressure gas activity tied to Gulf Coast LNG and solid contributions from Brazil, Gulf of America, Industrial Chemicals, and Production Testing. This performance highlights how TETRA’s exposure to specialized gas plays and industrial chemicals can bolster results even amid broader energy-sector volatility. We’ll...

Flutter Entertainment (NYSE:FLUT) has moved to concentrate its listing in the US, confirming plans to delist its ordinary shares from the London Stock Exchange and retain trading solely on the New York Stock Exchange. See our latest analysis for Flutter Entertainment. The LSE delisting decision lands at a time when Flutter Entertainment's share price has been under pressure, with the stock trading at US$98.51 and a year to date share price return that has fallen 54.87%, contributing to a 1...

Universal Display (OLED) came under pressure after reports that SK Hynix plans to slow its high bandwidth memory expansion. The news triggered a sector wide reaction across AI chip related stocks and raised fresh questions about sentiment versus fundamentals. See our latest analysis for Universal Display. At a share price of $87.56, Universal Display has seen its 1 day share price return recover 2.29% after the SK Hynix headlines. However, its year to date share price return is down 28.14%,...

Rackspace Technology (RXT) is in the spotlight after approving a workforce realignment that affects about 15% of staff and signing a definitive AI compute deployment agreement with Advanced Micro Devices, Inc. This signals a clear shift toward governed enterprise AI. See our latest analysis for Rackspace Technology. Those workforce cuts and the long term AI compute buildout with AMD arrive after a very large year to date share price return and a similarly strong 1 year total shareholder...

Blackstone (NYSE:BX) plans to invest $30b in artificial intelligence focused data centers in Japan. The company expects to deploy this capital over the next three to five years. The commitment targets Japan's growing data center infrastructure to support AI workloads. For investors tracking Blackstone, this move comes as the stock trades around $112.99, with performance under pressure in the near term. Shares are down 9.6% over the past week, 4.7% over the past month, and 28.8% year to...

Norwegian Cruise Line Holdings (NCLH) stock moved higher after oil prices fell 3% and director Stephen Pagliuca reported a sizeable share purchase, drawing attention to the company’s cost base and insider sentiment. See our latest analysis for Norwegian Cruise Line Holdings. Those twin signals, easing fuel costs and fresh insider buying, come after a mixed few months for Norwegian Cruise Line Holdings, with a 1 month share price return of 28.9% but a year to date share price decline of 7.8%,...

Investors may be wondering whether Axogen at US$42.52 still makes sense after such a strong run, or if the current price is getting ahead of itself. The stock has pulled back about 4.6% over the past week, after rising 4.0% over 30 days, 37.2% year to date, 314.8% over 1 year and 373.5% over 3 years, with a 96.8% return across 5 years. Recent coverage has focused on Axogen's share price performance and how the stock's sharp moves compare with broader medical equipment peers. This has put...

InvenTrust Properties (IVT) recently caught investor attention after being upgraded to a Zacks Rank #2. Rising earnings estimates and improving sentiment around its earnings prospects were cited as key drivers behind the move. See our latest analysis for InvenTrust Properties. InvenTrust Properties has already had a strong run in 2026, with a year to date share price return of 27.19% and a 1 year total shareholder return of 34.70%. The latest 90 day share price return of 16.26% suggests...

Leadership changes and technology focus at SEI Investments SEI Investments (SEIC) has been reshaping its leadership around technology, appointing Rob Wrzesniewski as Head of Stratos Technology and Matt Provencher as Global Head of Enterprise Professional Services to guide its advisor and enterprise platforms. See our latest analysis for SEI Investments. SEI Investments' leadership and platform updates come as the share price sits at US$88.89, with a 90 day share price return of 15.56% and a 3...

Popular (BPOP) is back in focus after an analyst upgrade linked to optimism around its earnings prospects and business fundamentals, a shift that often draws fresh attention from investors assessing bank stocks. See our latest analysis for Popular. Against that backdrop, Popular’s momentum has been firm, with a 30-day share price return of 10.07% and a year-to-date share price return of 31.51%. The 1-year total shareholder return of 56.94% and 3-year total shareholder return near 3x suggest...

In the recent past, GATX (NYSE:GATX) reported its latest quarterly results, posting year-on-year revenue growth but falling short of analyst expectations on key metrics. The mixed outcome highlights how even improving top-line performance can unsettle sentiment when it does not align with the market’s earnings forecasts. Next, we’ll examine how GATX’s revenue growth alongside an earnings miss might influence the existing investment narrative around railcar leasing demand. The latest GPUs...

In recent days, analysts have revised earnings estimates higher for Magnolia Oil & Gas, citing its focus on operational efficiency, disciplined capital allocation, and a solid balance sheet amid a challenging energy market. Although margins have come under some pressure, analysts point to Magnolia’s cash flow strength and concentration in high‑quality assets as supporting a more constructive outlook on its earnings potential. Next, we’ll examine how this renewed analyst confidence in...

Praxis Precision Medicines (PRAX) is back in focus after the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to elsunersen for seizures linked to rare SCN2A developmental and epileptic encephalopathy. See our latest analysis for Praxis Precision Medicines. The Breakthrough Therapy news lands after a very strong run for Praxis Precision Medicines, with the share price at $308.94 and recent moves mixing a 9.43% 7 day share price return with a 1 month share price...

Recent Phase II results for Dabogratinib, Tyra Biosciences (TYRA) experimental therapy for non-muscle invasive bladder cancer, have drawn fresh attention to the company, its late stage pipeline, and how the stock reflects that potential. See our latest analysis for Tyra Biosciences. Tyra Biosciences share price has been volatile around the latest Dabogratinib update, with a 1-day share price return of 1.03% and 7-day share price return of 4.47%, set against a 30-day share price return that is...

Recent updates show that Arcos Dorados has been outperforming the broader Retail-Wholesale sector, supported by a favorable Zacks Rank and rising full-year earnings estimates. Analysts are also highlighting that Arcos Dorados screens attractively on value metrics, with lower P/E and P/S ratios and a supportive PEG ratio relative to industry peers. Next, we will examine how the improving earnings outlook and value profile could influence Arcos Dorados' broader investment narrative. The best...

Merck KGaA, traded in the U.S. via NYSE:MRK, agreed to acquire Bio-Techne Corporation in an US$11.3b transaction. The deal is structured to expand Merck KGaA’s reach in life sciences tools, diagnostics, and biomanufacturing support. The acquisition is intended to strengthen Merck KGaA’s position in the U.S. life sciences market and broaden its capabilities across the drug development value chain. For investors following Merck, this deal increases attention on the company’s life sciences...

Daktronics, Inc. recently reported fourth-quarter 2026 sales of US$208.61 million and net income of US$8.42 million, alongside full-year sales of US$838.71 million and net income of US$45.38 million, marking a shift from losses a year earlier. At the same time, Daktronics increased its equity buyback authorization to US$40 million, underlining management’s confidence in the company’s financial position and cash-generation profile. We’ll now look at how Daktronics’ move from loss to profit...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Himax...

CEO succession and restructuring reshape the Mohawk Industries story Investor sentiment around Mohawk Industries (MHK) has shifted after the company outlined a CEO succession plan and highlighted restructuring efforts aimed at improving operational margins, drawing fresh attention to the stock. The transition centers on Paul F. De Cock, currently President and Chief Operating Officer and Interim President Flooring Rest of the World, who is scheduled to become Chief Executive Officer on...

Recent Share Performance and Business Snapshot Aurinia Pharmaceuticals (NasdaqGM:AUPH) has drawn investor attention after a recent move in its stock price, with the shares last closing at $18.62 and recent returns showing double digit moves over the past year. The company, which focuses on therapies for autoimmune diseases, reports revenue of $298.295 million and net income of $298.213 million, primarily from research, development and commercialization of therapeutic drugs, including its...

The streaming story is being rewritten in real time, as Paramount Skydance’s planned US$111b purchase of Warner Bros Discovery and Fox Corporation’s US$22b move on Roku unsettle investors and raise questions about which stocks might handle the shake up best. With bundled cable TV giving way to thinner streaming margins and fiercer competition from Apple, Amazon, YouTube and TikTok, select companies could either benefit from the disruption or feel more pressure. This article picks out 3 stocks...

MGM Resorts International and BetMGM recently renewed their multi‑year partnerships with Major League Baseball, keeping MGM as MLB’s exclusive Integrated Resort & Casino Partner and extending BetMGM’s marketing presence across MLB media, events, and co‑branded gaming products in the U.S. and Canada. This renewal strengthens MGM’s access to baseball fans through awards events in Las Vegas, team partnerships, and MLB‑themed betting and casino experiences, potentially deepening the link between...